Skip to main content
. 2014 Aug 22;9(8):e104474. doi: 10.1371/journal.pone.0104474

Figure 2. Proportion of resistance mutations in sequences from treatment naïve and treatment experienced patients identified between 2001 and 2011.

Figure 2

A Proportion of resistance mutations in first Prot/RT sequence from treatment naïve patients (n = 1950; mutations with ≥0.3% shown) according to SDRM mutation list (Bennett 2009 et al.). B Proportion of resistance mutations in sequences from treated patients (Prot/RT n = 2,049; Int n = 150) according to IAS mutation list 2011. Bars in black: NRTI mutations, grey bars: TAMS, white bars: NNRTI mutations, bars in light grey: PI mutations, dark grey bars: INI mutations.